Study to Assess Pharmacokinetics, Safety, and Tolerability of MT-7117 in Subjects With Normal and Impaired Hepatic Function
NCT04116476
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
23
Enrollment
INDUSTRY
Sponsor class
Conditions
Mild and Moderate Hepatic Impairment
Interventions
DRUG:
MT-7117
Sponsor
Tanabe Pharma America, Inc.